Vifor Pharma
Vifor Pharma
Explore linked clinical trials.1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency | Iron Deficiencies, Nutritional and Metabolic Diseases, cardiovascular disorder, heart disorder, heart failure, iron metabolism disease, metabolic disease, systolic heart failure | Not yet recruiting | Phase 3 | 2024-06-03 | NCT06434025 |